Literatur zum Artikel: Update kongenitale Muskeldystrophien und Gliedergürteldystrophien

• Literatur

• 1 Kissel JT, Mendell JR. Muscular dystrophy: historical overview and classification in the genetic era. Semin Neurol 1999; 19 (01) 5-7.
• 2 Voit T. Congenital muscular dystrophies: 1997 update. Brain Dev 1998; 20 (02) 65-74.
• 3 Brais B, Rouleau GA, Bouchard JP, Fardeau M, Tome FM. Oculopharyngeal muscular dystrophy. Semin Neurol 1999; 19 (01) 59-66.
• 4 Emery AE. Population frequencies of inherited neuromuscular diseases – a world survey. Neuromuscul Disord 1991; 1 (01) 19-29.
• 5 Mukoyama M, Kondo K, Hizawa K, Nishitani H. Life spans of Duchenne muscular dystrophy patients in the hospital care program in Japan. J Neurol Sci 1987; 81 (2–3) 155-8.
• 6 Walter MC, Lochmuller H. Novel approaches to treat muscular dystrophies. Expert Opin Investig Drugs 2001; 10 (04) 695-707.
• 7 Hoffman EP, Brown Jr RH, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987; 51 (06) 919-28.
• 8 Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 1987; 50 (03) 509-17.
• 9 Mendell JR, Kissel JT, Amato AA, King W, Signore L, Prior TW. et al. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N Engl J Med 1995; 333 (13) 832-8.
• 10 van den Bergh PY, Tome FM, Fardeau M. Etiology and pathogenesis of the muscular dystrophies. Acta Neurol Belg 1995; 95 (03) 123-41.
• 11 Duchenne G. De l´electrisation localisée et de son application à la pathologie et à la therapeutique. In: Paris: Bailliere et Fils; 1861
• 12 Duchenne G. Recherches surla paralysis musculaire pseudohypertrophique on paralysis myosclerosique. Ach Gen Med 1868; (11) 5-25.
• 13 Monaco AP, Bertelson CJ, Liechti-Gallati S, Moser H, Kunkel LM. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 1988; 2 (01) 90-5.
• 14 Batten F. Three cases of myopathy, infantile type. Brain 1903; 26: 147-48.
• 15 Bell J. On pseudohypertrophic and allied types of progressive muscular dystrophy. In: Fischer RA. (ed). The treasury of human inheritance. London: Cambrigde University Press; 1943: 283-342.
• 16 Bushby KM. Diagnostic criteria for the limb-girdle muscular dystrophies: report of the ENMC Consortium on Limb-Girdle Dystrophies. Neuromuscul Disord 1995; 5 (01) 71-4.
• 17 Brockington M, Blake DJ, Brown SC, Muntoni F. The gene for a novel glycosyltransferase is mutated in congenital muscular dystrophy MDC1C and limb girdle muscular dystrophy 2I. Neuromuscul Disord 2002; 12 (03) 233-4.
• 18 Brockington M, Blake DJ, Prandini P, Brown SC, Torelli S, Benson MA. et al. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am J Hum Genet 2001; 69 (06) 1198-209.
• 19 Balci B, Uyanik G, Dincer P, Gross C, Willer T, Talim B. et al. An autosomal recessive limb girdle muscular dystrophy (LGMD2) with mild mental retardation is allelic to Walker-Warburg syndrome (WWS) caused by a mutation in the POMT1 gene. Neuromuscul Disord 2005; 15 (04) 271-5.
• 20 Dincer P, Balci B, Yuva Y, Talim B, Brockington M, Dincel D. et al. A novel form of recessive limb girdle muscular dystrophy with mental retardation and abnormal expression of alpha-dystroglycan. Neuromuscul Disord 2003; 13 (10) 771-8.
• 21 Bione S, Maestrini E, Rivella S, Mancini M, Regis S, Romeo G. et al. Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nat Genet 1994; 8 (04) 323-7.
• 22 Bonne G, Di Barletta MR, Varnous S, Becane HM, Hammouda EH, Merlini L. et al. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet 1999; 21 (03) 285-8.
• 23 Fatkin D, MacRae C, Sasaki T, Wolff MR, Porcu M, Frenneaux M. et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 1999; 341 (23) 1715-24.
• 24 Muchir A, Bonne G, van der Kooi AJ, van Meegen M, Baas F, Bolhuis PA. et al. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum Mol Genet 2000; 9 (09) 1453-9.
• 25 de Sandre-Giovannoli A, Chaouch M, Kozlov S, Vallat JM, Tazir M, Kassouri N. et al. Homozygous defects in LMNA, encoding lamin A/C nuclearenvelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am J Hum Genet 2002; 70 (03) 726-36.
• 26 Bonne G. [The laminopathy saga]. Rev Neurol 2003; 37 (08) 772-4.
• 27 Bonne G, Yaou RB, Beroud C, Boriani G, Brown S, de Visser M. et al. 108th ENMC International Workshop, 3rd Workshop of the MYO-CLUSTER project: EUROMEN, 7th International Emery-Dreifuss Muscular Dystrophy (EDMD) Workshop, 13–15 September 2002, Naarden, The Netherlands. Neuromuscul Disord 2003; 13 (06) 508-15.
• 28 Kirschner J, Brune T, Wehnert M, Denecke J, Wasner C, Feuer A. et al. p.S143F mutation in lamin A/C: a new phenotype combining myopathy and progeria. Ann Neurol 2005; 57 (01) 148-51.
• 29 Mathews KD, Moore SA. Limb-girdle muscular dystrophy. Curr Neurol Neurosci Rep 2003; 3 (01) 78-85.
• 30 Urtasun M, Saenz A, Roudaut C, Poza JJ, Urtizberea JA, Cobo AM. et al. Limb-girdle muscular dystrophy in Guipuzcoa (Basque Country, Spain). Brain 1998; 121 (Suppl. 09) 1735-47.
• 31 Zatz M, de Paula F, Starling A, Vainzof M. The 10 autosomal recessive limb-girdle muscular dystrophies. Neuromuscul Disord 2003; 13 (7–8) 532-44.
• 32 Zatz M, Vainzof M, Passos-Bueno MR. Limb-girdle muscular dystrophy: one gene with different phenotypes, one phenotype with different genes. Curr Opin Neurol 2000; 13 (05) 511-7.
• 33 Bushby KM, Beckmann JS. The 105th ENMC sponsored workshop: pathogenesis in the non-sarcoglycan limb-girdle muscular dystrophies, Naarden, April 12–14, 2002. Neuromuscul Disord 2003; 13 (01) 80-90.
• 34 Beckmann JS, Brown RH, Muntoni F, Urtizberea A, Bonnemann C, Bushby KM. 66th/67th ENMC sponsored international workshop: The limb-girdle muscular dystrophies, 26–28 March 1999, Naarden, The Netherlands. Neuromuscul Disord 1999; 9 (6–7) 436-45.
• 35 Fardeau M, Hillaire D, Mignard C, Feingold N, Feingold J, Mignard D. et al. Juvenile limb-girdle muscular dystrophy. Clinical, histopathological and genetic data from a small community living in the Reunion Island. Brain 1996; 119 (Suppl. 01) 295-308.
• 36 Richard I, Broux O, Allamand V, Fougerousse F, Chiannilkulchai N, Bourg N. et al. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 1995; 81 (01) 27-40.
• 37 Richard I, Roudaut C, Saenz A, Pogue R, Grimbergen JE, Anderson LV. et al. Calpainopathy-a survey of mutations and polymorphisms. Am J Hum Genet 1999; 64 (06) 1524-40.
• 38 Saenz A, Leturcq F, Cobo AM, Poza JJ, Ferrer X, Otaegui D. et al. LGMD2A: genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene. Brain 2005; 128 (Suppl. 04) 732-42.
• 39 Betz RC, Schoser BG, Kasper D, Ricker K, Ramirez A, Stein V. et al. Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease. Nat Genet 2001; 28 (03) 218-9.
• 40 de Paula F, Vainzof M, Bernardino AL, McNally E, Kunkel LM, Zatz M. Mutations in the caveolin-3 gene: When are they pathogenic?. Am J Med Genet 2001; 99 (04) 303-7.
• 41 Minetti C, Sotgia F, Bruno C, Scartezzini P, Broda P, Bado M. et al. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet 1998; 18 (04) 365-8.
• 42 Bansal D, Miyake K, Vogel SS, Groh S, Chen CC, Williamson R. et al. Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature 2003; 423 (6936) 168-72.
• 43 Bashir R, Britton S, Strachan T, Keers S, Vafiadaki E, Lako M. et al. A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet 1998; 20 (01) 37-42.
• 44 Illa I, Serrano-Munuera C, Gallardo E, Lasa A, Rojas-Garcia R, Palmer J. et al. Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype. Ann Neurol 2001; 49 (01) 130-4.
• 45 Miyoshi K, Saijo K, Kuryu T, Tada Y, Otsuka Y, Oshima Y. et al. Four cases of distal myopathy in two families. Jpn J Hum Genet 1967; 12: 113.
• 46 Ueyama H, Kumamoto T, Horinouchi H, Fujimoto S, Aono H, Tsuda T. Clinical heterogeneity in dysferlinopathy. Intern Med 2002; 41 (07) 532-6.
• 47 Walter MC, Braun C, Vorgerd M, Poppe M, Thirion C, Schmidt C. et al. Variable reduction of caveolin-3 in patients with LGMD2B/MM. J Neurol 2003; 250 (12) 1431-8.
• 48 Weiler T, Bashir R, Anderson LV, Davison K, Moss JA, Britton S. et al. Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s). Hum Mol Genet 1999; 8 (05) 871-7.
• 49 Bonnemann CG, Modi R, Noguchi S, Mizuno Y, Yoshida M, Gussoni E. et al. Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat Genet 1995; 11 (03) 266-73.
• 50 Nigro V, de Sa Moreira E, Piluso G, Vainzof M, Belsito A, Politano L. et al. Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene. Nat Genet 1996; 14 (02) 195-8.
• 51 Noguchi S, McNally EM, Ben Othmane K, Hagiwara Y, Mizuno Y, Yoshida M. et al. Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy. Science 1995; 270 (5237) 819-22.
• 52 Roberds SL, Leturcq F, Allamand V, Piccolo F, Jeanpierre M, Anderson RD. et al. Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell 1994; 78 (04) 625-33.
• 53 Hauser MA, Conde CB, Kowaljow V, Zeppa G, Taratuto AL, Torian UM. et al. Myotilin mutation found in second pedigree with LGMD1A. Am J Hum Genet 2002; 71 (06) 1428-32.
• 54 Hauser MA, Horrigan SK, Salmikangas P, Torian UM, Viles KD, Dancel R. et al. Myotilin is mutated in limb girdle muscular dystrophy 1A. Hum Mol Genet 2000; 9 (14) 2141-7.
• 55 Selcen D, Engel AG. Mutations in myotilin cause myofibrillar myopathy. Neurology 2004; 62 (08) 1363-71.
• 56 Speer MC, Yamaoka LH, Gilchrist JH, Gaskell CP, Stajich JM, Vance JM. et al. Confirmation of genetic heterogeneity in limb-girdle muscular dystrophy: linkage of an autosomal dominant form to chromosome 5q. Am J Hum Genet 1992; 50 (06) 1211-7.
• 57 Moreira ES, Vainzof M, Marie SK, Sertie AL, Zatz M, Passos-Bueno MR. The seventh form of autosomal recessive limb-girdle muscular dystrophy is mapped to 17q11–12. Am J Hum Genet 1997; 61 (01) 151-9.
• 58 Moreira ES, Wiltshire TJ, Faulkner G, Nilforoushan A, Vainzof M, Suzuki OT. et al. Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethonin. Nat Genet 2000; 24 (02) 163-6.
• 59 Hackman JP, Vihola AK, Udd AB. The role of titin in muscular disorders. Ann Med 2003; 35 (06) 434-41.
• 60 Hackman P, Vihola A, Haravuori H, Marchand S, Sarparanta J, De Seze J. et al. Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin. Am J Hum Genet 2002; 71 (03) 492-500.
• 61 Udd B. Limb-girdle type muscular dystrophy in a large family with distal myopathy: homozygous manifestation of a dominant gene?. J Med Genet 1992; 29 (06) 383-9.
• 62 Udd B, Partanen J, Halonen P, Falck B, Hakamies L, Heikkila H. et al. Tibial muscular dystrophy. Late adult-onset distal myopathy in 66 Finnish patients. Arch Neurol 1993; 50 (06) 604-8.
• 63 Udd B, Vihola A, Sarparanta J, Richard I, Hackman P. Titinopathies and extension of the M-line mutation phenotype beyond distal myopathy and LGMD2J. Neurology 2005; 64 (04) 636-42.
• 64 Bonne G, Mercuri E, Muchir A, Urtizberea A, Becane HM, Recan D. et al. Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene. Ann Neurol 2000; 48 (02) 170-80.
• 65 van der Kooi AJ, Ledderhof TM, de Voogt WG, Res CJ, Bouwsma G, Troost D. et al. A newly recognized autosomal dominant limb girdle muscular dystrophy with cardiac involvement. Ann Neurol 1996; 39 (05) 636-42.
• 66 van der Kooi AJ, van Meegen M, Ledderhof TM, McNally EM, de Visser M, Bolhuis PA. Genetic localization of a newly recognized autosomal dominant limb-girdle muscular dystrophy with cardiac involvement (LGMD1B) to chromosome 1q11–21. Am J Hum Genet 1997; 60 (04) 891-5.
• 67 Frosk P, Weiler T, Nylen E, Sudha T, Greenberg CR, Morgan K. et al. Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene. Am J Hum Genet 2002; 70 (03) 663-72.
• 68 Weiler T, Greenberg CR, Zelinski T, Nylen E, Coghlan G, Crumley MJ. et al. A gene for autosomal recessive limb-girdle muscular dystrophy in Manitoba Hutterites maps to chromosome region 9q31-q33: evidence for another limb-girdle muscular dystrophy locus. Am J Hum Genet 1998; 63 (01) 140-7.
• 69 Brockington M, Sewry CA, Herrmann R, Naom I, Dearlove A, Rhodes M. et al. Assignment of a form of congenital muscular dystrophy with secondary merosin deficiency to chromosome 1q42. Am J Hum Genet 2000; 66 (02) 428-35.
• 70 Brockington M, Yuva Y, Prandini P, Brown SC, Torelli S, Benson MA. et al. Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet 2001; 10 (25) 2851-9.
• 71 Poppe M, Bourke J, Eagle M, Frosk P, Wrogemann K, Greenberg C. et al. Cardiac and respiratory failure in limb-girdle muscular dystrophy 2I. Ann Neurol 2004; 56 (05) 738-41.
• 72 Poppe M, Cree L, Bourke J, Eagle M, Anderson LV, Birchall D. et al. The phenotype of limb-girdle muscular dystrophy type 2I. Neurology 2003; 60 (08) 1246-51.
• 73 Walter MC, Petersen JA, Stucka R, Fischer D, Schroder R, Vorgerd M. et al. FKRP (826C>A) frequently causes limb-girdle muscular dystrophy in German patients. J Med Genet 2004; 41 (04) e50.
• 74 Topaloglu H, Brockington M, Yuva Y, Talim B, Haliloglu G, Blake D. et al. FKRP gene mutations cause congenital muscular dystrophy, mental retardation, and cerebellar cysts. Neurology 2003; 60 (06) 988-92.
• 75 de Paula F, Vieira N, Starling A, Yamamoto LU, Lima B, de Cassia Pavanello R. et al. Asymptomatic carriers for homozygous novel mutations in the FKRP gene: the other end of the spectrum. Eur J Hum Genet 2003; 11 (12) 923-30.
• 76 Wicklund MP, Hilton-Jones D. The limb-girdle muscular dystrophies: genetic and phenotypic definition of a disputed entity. Neurology 2003; 60 (08) 1230-1.
• 77 Kirschner J, Bonnemann CG. The congenital and limb-girdle muscular dystrophies: sharpening the focus, blurring the boundaries. Arch Neurol 2004; 61 (02) 189-99.
• 78 Raffaele Di, Barletta M, Ricci E, Galluzzi G, Tonali P, Mora M, Morandi L. et al. Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. Am J Hum Genet 2000; 66 (04) 1407-12.
• 79 Walter MC, Witt TN, Weigel BS, Reilich P, Richard P, Pongratz D. et al. Deletion of the LMNA initiator codon leading to a neurogenic variant of autosomal dominant Emery-Dreifuss muscular dystrophy. Neuromuscul Disord 2005; 15 (01) 40-4.
• 80 Schara U. Neuromuskuläre Erkrankungen im Kindes-und Jugendalter. Neuropädiatrie in Klinik und Praxis 2006; 5 (01) 6-30.
• 81 Muntoni F, Valero de Bernabe B, Bittner R, Blake D, van Bokhoven H, Brockington M. et al. 114th ENMC International Workshop on Congenital Muscular Dystrophy (CMD) 17–19 January 2003, Naarden, The Netherlands: (8th Workshop of the International Consortium on CMD; 3rd Workshop of the MYO-CLUSTER project GENRE). Neuromuscul Disord 2003; 13 (7–8) 579-88.
• 82 Muntoni F, Voit T. The congenital muscular dystrophies in 2004: a century of exciting progress. Neuromuscul Disord 2004; 14 (10) 635-49.
• 83 Endo T. Aberrant glycosylation of alpha-dystroglycan and congenital muscular dystrophies. Acta Myol 2005; 24 (02) 64-9.
• 84 Chiyonobu T, Sasaki J, Nagai Y, Takeda S, Funakoshi H, Nakamura T. et al. Effects of fukutin deficiency in the developing mouse brain. Neuromuscul Disord 2005; 15 (06) 416-26.
• 85 Ferreira LG, Marie SK, Liu EC, Resende MB, Carvalho MS, Scaff M. et al. Dystrophin-glycoproteins associated in congenital muscular dystrophy: immunohistochemical analysis of 59 Brazilian cases. Arq Neuropsiquiatr 2005; 63 (3B) 791-800.
• 86 Mercuri E, Jungbluth H, Muntoni F. Muscle imaging in clinical practice: diagnostic value of muscle magnetic resonance imaging in inherited neuromuscular disorders. Curr Opin Neurol 2005; 18 (05) 526-37.
• 87 von der Hagen M, Schallner J, Kaindl AM, Koehler K, Mitzscherling P, Abicht A. et al. Facing the genetic heterogeneity in neuromuscular disorders: linkage analysis as an economic diagnostic approach towards the molecular diagnosis. Neuromuscul Disord 2006; 16 (01) 4-13.
• 88 von der Hagen M, Schallner J, Kaindl AM, Koehler K, Mitzscherling P, Abicht A. et al. Facing the genetic heterogeneity in neuromuscular disorders: Linkage analysis as an economic diagnostic approach towards the molecular diagnosis. Neuromuscul Disord; 2005
• 89 Eagle M, Baudouin SV, Chandler C, Giddings DR, Bullock R, Bushby K. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord 2002; 12 (10) 926-9.
• 90 Mellies U, Dohna-Schwake C, Voit T. Respiratory function assessment and intervention in neuromuscular disorders. Curr Opin Neurol 2005; 18 (05) 543-7.
• 91 Bogdanovich S, Perkins KJ, Krag TO, Khurana TS. Therapeutics for Duchenne muscular dystrophy: current approaches and future directions. J Mol Med 2004; 82 (02) 102-15.
• 92 van Deutekom JC, Bremmer-Bout M, Janson AA, Ginjaar IB, Baas F, den Dunnen JT. et al. Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells. Hum Mol Genet 2001; 10 (15) 1547-54.
• 93 Bentzinger CF, Barzaghi P, Lin S, Ruegg MA. Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-alpha2-deficient mice. Faseb J 2005; 19 (08) 934-42.
• 94 Brockington M, Torelli S, Prandini P, Boito C, Dolatshad NF, Longman C. et al. Localization and functional analysis of the LARGE family of glycosyltransferases: significance for muscular dystrophy. Hum Mol Genet 2005; 14 (05) 657-65.
• 95 Becker PE. Two new families of benign sex-linked recessive muscular dystrophy. Rev Canad Biol 1962; 21: 551-66.
• 96 Becker PE. Eine neue X-chromosomale Muskeldystrophie. Acta Psychiat Neurol Scand 1955; 193: 427.
• 97 Fadda S, Mochi M, Roncuzzi L, Sangiorgi S, Sbarra D, Zatz M. et al. Definitive localization of Becker muscular dystrophy in Xp by linkage to a cluster of DNA polymorphisms (DXS43 and DXS9). Hum Genet 1985; 71 (01) 33-6.
• 98 Speer MC, Vance JM, Grubber JM, Lennon Graham F, Stajich JM, Viles KD. et al. Identification of a new autosomal dominant limb-girdle muscular dystrophy locus on chromosome 7. Am J Hum Genet 1999; 64 (02) 556-62.
• 99 Messina DN, Speer MC, Pericak-Vance MA, McNally EM. Linkage of familial dilated cardiomyopathy with conduction defect and muscular dystrophy to chromosome 6q23. Am J Hum Genet 1997; 61 (04) 909-17.
• 100 Gamez J, Navarro C, Andreu AL, Fernandez JM, Palenzuela L, Tejeira S. et al. Autosomal dominant limb-girdle muscular dystrophy: a large kindred with evidence for anticipation. Neurology 2001; 56 (04) 450-4.
• 101 Palenzuela L, Andreu AL, Gamez J, Vila MR, Kunimatsu T, Meseguer A. et al. A novel autosomal dominant limb-girdle muscular dystrophy (LGMD 1F) maps to 7q32.1–32.2. Neurology 2003; 61 (03) 404-6.
• 102 Starling A, Kok F, Passos-Bueno MR, Vainzof M, Zatz M. A new form of autosomal dominant limb-girdle muscular dystrophy (LGMD1G) with progressive fingers and toes flexion limitation maps to chromosome 4p21. Eur J Hum Genet 2004; 12 (12) 1033-40.
• 103 Driss A, Amouri R, Ben Hamida C, Souilem S, Gouider-Khouja N, Ben Hamida M. et al. A new locus for autosomal recessive limb-girdle muscular dystrophy in a large consanguineous Tunisian family maps to chromosome 19q13.3. Neuromuscul Disord 2000; 10 (4–5) 240-6.
• 104 Driss A, Noguchi S, Amouri R, Kefi M, Sasaki T, Sugie K. et al. Fukutin-related protein gene mutated in the original kindred limb-girdle MD 2I. Neurology 2003; 60 (08) 1341-4.
• 105 Esapa CT, McIlhinney RA, Blake DJ. Fukutin-related protein mutations that cause congenital muscular dystrophy result in ER-retention of the mutant protein in cultured cells. Hum Mol Genet 2005; 14 (02) 295-305.
• 106 Frosk P, Greenberg CR, Tennese AA, Lamont R, Nylen E, Hirst C. et al. The most common mutation in FKRP causing limb girdle muscular dystrophy type 2I (LGMD2I) may have occurred only once and is present in Hutterites and other populations. Hum Mutat 2005; 25 (01) 38-44.
• 107 Karpati G, Holland P. Sweetening the pot in muscle: genetic defects of protein glycosylation causing muscle disease. Neurology 2002; 59 (11) 1674-6.
• 108 Mercuri E, Brockington M, Straub V, Quijano-Roy S, Yuva Y, Herrmann R. et al. Phenotypic spectrum associated with mutations in the fukutin-related protein gene. Ann Neurol 2003; 53 (04) 537-42.
• 109 Koss-Harnes D, Hoyheim B, Jonkman MF, de Groot WP, de Weerdt CJ, Nikolic B. et al. Life-long course and molecular characterization of the original Dutch family with epidermolysis bullosa simplex with muscular dystrophy due to a homozygous novel plectin point mutation. Acta Derm Venereol 2004; 84 (02) 124-31.
• 110 Shimizu H, Takizawa Y, Pulkkinen L, Murata S, Kawai M, Hachisuka H. et al. Epidermolysis bullosa simplex associated with muscular dystrophy: phenotype-genotype correlations and review of the literature. J Am Acad Dermatol 1999; 41 (06) 950-6.
• 111 Mostacciuolo ML, Miorin M, Martinello F, Angelini C, Perini P, Trevisan CP. Genetic epidemiology of congenital muscular dystrophy in a sample from north-east Italy. Hum Genet 1996; 97 (03) 277-9.
• 112 Mendell JR, Sahenk Z, Prior TW. The childhood muscular dystrophies: diseases sharing a common pathogenesis of membrane instability. J Child Neurol 1995; 10 (02) 150-9.
• 113 Fukuyama Y, Osawa M, Suzuki H. Congenital progressive muscular dystrophy of the Fukuyama type – clinical, genetic and pathological considerations. Brain Dev 1981; 3 (01) 1-29.
• 114 Silan F, Yoshioka M, Kobayashi K, Simsek E, Tunc M, Alper M. et al. A new mutation of the fukutin gene in a non-Japanese patient. Ann Neurol 2003; 53 (03) 392-6.
• 115 Santavuori P, Somer H, Sainio K, Rapola J, Kruus S, Nikitin T. et al. Muscle-eye-brain disease (MEB). Brain Dev 1989; 11 (03) 147-53.
• 116 Yoshida A, Kobayashi K, Manya H, Taniguchi K, Kano H, Mizuno M. et al. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev Cell 2001; 1 (05) 717-24.
• 117 Beltran-Valero de Bernabe D, Currier S, Steinbrecher A, Celli J, van Beusekom E, van der Zwaag B. et al. Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am J Hum Genet 2002; 71 (05) 1033-43.
• 118 Dobyns WB, Pagon RA, Armstrong D, Curry CJ, Greenberg F, Grix A. et al. Diagnostic criteria for Walker-Warburg syndrome. Am J Med Genet 1989; 32 (02) 195-210.
• 119 Helbling-Leclerc A, Zhang X, Topaloglu H, Cruaud C, Tesson F, Weissenbach J. et al. Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet 1995; 11 (02) 216-8.
• 120 Jones KJ, Morgan G, Johnston H, Tobias V, Ouvrier RA, Wilkinson I. et al. The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: case series and review. J Med Genet 2001; 38 (10) 649-57.
• 121 Muntoni F, Taylor J, Sewry CA, Naom I, Dubowitz V. An early onset muscular dystrophy with diaphragmatic involvement, early respiratory failure and secondary alpha2 laminin deficiency unlinked to the LAMA2 locus on 6q22. Eur J Paediatr Neurol 1998; 2 (01) 19-26.
• 122 Longman C, Brockington M, Torelli S, Jimenez-Mallebrera C, Kennedy C, Khalil N. et al. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Hum Mol Genet 2003; 12 (21) 2853-61.
• 123 Ferreiro A, Ceuterick-de Groote C, Marks JJ, Goemans N, Schreiber G, Hanefeld F. et al. Desmin-related myopathy with Mallory body-like inclusions is caused by mutations of the selenoprotein N gene. Ann Neurol 2004; 55 (05) 676-86.
• 124 Ferreiro A, Quijano-Roy S, Pichereau C, Moghadaszadeh B, Goemans N, Bonnemann C. et al. Mutations of the selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: reassessing the nosology of early-onset myopathies. Am J Hum Genet 2002; 71 (04) 739-49.
• 125 Moghadaszadeh B, Desguerre I, Topaloglu H, Muntoni F, Pavek S, Sewry C. et al. Identification of a new locus for a peculiar form of congenital muscular dystrophy with early rigidity of the spine, on chromosome 1p35–36. Am J Hum Genet 1998; 62 (06) 1439-45.
• 126 Hayashi YK, Chou FL, Engvall E, Ogawa M, Matsuda C, Hirabayashi S. et al. Mutations in the integrin alpha7 gene cause congenital myopathy. Nat Genet 1998; 19 (01) 94-7.
• 127 Baker NL, Morgelin M, Peat R, Goemans N, North KN, Bateman JF. et al. Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy. Hum Mol Genet 2005; 14 (02) 279-93.
• 128 Camacho Vanegas O, Bertini E, Zhang RZ, Petrini S, Minosse C, Sabatelli P. et al. Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI. Proc Natl Acad Sci USA 2001; 98 (13) 7516-21.
• 129 Demir E, Ferreiro A, Sabatelli P, Allamand V, Makri S, Echenne B. et al. Collagen VI status and clinical severity in Ullrich congenital muscular dystrophy: phenotype analysis of 11 families linked to the COL6 loci. Neuropediatrics 2004; 35 (02) 103-12.
• 130 Demir E, Sabatelli P, Allamand V, Ferreiro A, Moghadaszadeh B, Makrelouf M. et al. Mutations in COL6A3 cause severe and mild phenotypes of Ullrich congenital muscular dystrophy. Am J Hum Genet 2002; 70 (06) 1446-58.
• 131 Higuchi I, Shiraishi T, Hashiguchi T, Suehara M, Niiyama T, Nakagawa M. et al. Frameshift mutation in the collagen VI gene causes Ullrich's disease. Ann Neurol 2001; 50 (02) 261-5.
• 132 Mercuri E, Yuva Y, Brown SC, Brockington M, Kinali M, Jungbluth H. et al. Collagen VI involvement in Ullrich syndrome: a clinical, genetic, and immunohistochemical study. Neurology 2002; 58 (09) 1354-9.
• 133 Pan TC, Zhang RZ, Sudano DG, Marie SK, Bonnemann CG, Chu ML. New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype. Am J Hum Genet 2003; 73 (02) 355-69.
• 134 Pepe G, Bertini E, Bonaldo P, Bushby K, Giusti B, de Visser M. et al. Bethlem myopathy (BETHLEM) and Ullrich scleroatonic muscular dystrophy: 100th ENMC international workshop, 23–24 November 2001, Naarden, The Netherlands. Neuromuscul Disord 2002; 12 (10) 984-93.
• 135 Pepe G, de Visser M, Bertini E, Bushby K, Vanegas OC, Chu ML. et al. Bethlem myopathy (BETHLEM) 86th ENMC international workshop, 10–11 November 2000, Naarden, The Netherlands. Neuromuscul Disord 2002; 12 (03) 296-305.
• 136 Ullrich O. Kongentiale atonisch-sklerotische Muskeldystrophie, ein weiterer Typus der heredodegenerativen Erkrankungen des neuromuskulären Systems. Z Ges Neurol Psychiatr 1930; 126: 171-201.
• 137 Dalkilic I, Kunkel LM. Muscular dystrophies: genes to pathogenesis. Curr Opin Genet Dev 2003; 13 (03) 231-8.